C
Cyrus Cooper
Researcher at Southampton General Hospital
Publications - 1961
Citations - 248928
Cyrus Cooper is an academic researcher from Southampton General Hospital. The author has contributed to research in topics: Population & Osteoporosis. The author has an hindex of 204, co-authored 1869 publications receiving 206782 citations. Previous affiliations of Cyrus Cooper include University of Oxford & University of York.
Papers
More filters
Journal ArticleDOI
Risk of fracture in patients with Parkinson's disease
S Pouwels,Marloes T Bazelier,A. de Boer,Wim E.J. Weber,Cees Neef,Cyrus Cooper,Cyrus Cooper,F. de Vries +7 more
TL;DR: Fracture risk assessment may be indicated among patients with PD, in particular when they have recently used selective serotonin re-uptake inhibitors or high-dose antipsychotics, or have a history of fracture, falling, low body mass index (BMI) or renal disease.
Journal ArticleDOI
Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial.
Cyrus Cooper,Jean-Yves Reginster,Roland Chapurlat,Claus Christiansen,Harry K. Genant,Nicholas Bellamy,William G. Bensen,Federico Navarro,J. Badurski,Evgeny Nasonov,Xavier Chevalier,Philip N. Sambrook +11 more
TL;DR: This randomised, double blind, placebo-controlled study will establish the potential of strontium ranelate in improving structure and symptoms in patients with knee osteoarthritis.
Journal ArticleDOI
PTH/PTHrP activity and the programming of skeletal development in utero.
Jonathan H Tobias,Cyrus Cooper +1 more
TL;DR: Preliminary findings from birth cohort studies suggest that maternal calcium intake and cord blood calcium levels are positively related to bone mass of the offspring as assessed later in childhood and to identify modifiable maternal factors that are responsible for these changes.
Journal ArticleDOI
Circulating cortisone levels are associated with biochemical markers of bone formation and lumbar spine BMD: the Hertfordshire Cohort Study.
Mark S. Cooper,Holly E. Syddall,Caroline H.D. Fall,Peter J. Wood,Paul M. Stewart,Cyrus Cooper,Elaine M. Dennison +6 more
TL;DR: The impact of 11β‐HSD1 activity on bone in vivo is measured by examining the association of circulating cortisone with bone markers, bone mineral density (BMD) and bone loss in a cohort of women and men.
Journal ArticleDOI
Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO)
Cyrus Cooper,Franz Jakob,C Chinn,E Martin-Mola,Patrice Fardellone,S. Adami,N C Thalassinos,J Melo-Gomes,David J. Torgerson,A Gibson,Fernando Marin +10 more
TL;DR: Those with a fracture at baseline were more likely to sustain an incident fracture and have a worse health-related quality of life than those without prior fracture.